[1] |
Morelli S., Salerno S., Piscioneri A., Tasselli F., Drioli E., De Bartolo L., Chemical Engineering Journal,2016, 305(1), 69—78
|
[2] |
Chen N., Sun Y., Yue H., Liu S. Y., Chem. J. Chinese Universities,2013, 34(5), 1111—1114
|
|
(陈宁, 孙一, 越皓, 刘淑莹. 高等学校化学学报, 2013, 34(5), 1111—1114)
|
[3] |
Chen S. D., Yang H. Q., Geriatric Medicine And Health,2004, 11(4), 193—198
|
|
(陈生弟, 杨红旗. 老年医学与保健, 2004, 11(4), 193—198)
|
[4] |
Long Y., Zheng Y. C., Chinese Pharmacists,2009, 12(12), 1828—1829
|
|
(龙悦, 郑永昌. 中国药师, 2009, 12(12), 1828—1829)
|
[5] |
Fu J. L., Shao F. Y., The World of Clinical Medicine,2010, 31(7), 390—394
|
|
(付剑凉, 邵福源. 世界临床医药, 2010, 31(7), 390—394)
|
[6] |
Zhang X., Yong X. C., Zhang T., China's Pharmaceutical Information,2010, 26(4), 4—18
|
|
(张骁, 雍晓春, 张韬. 中国制药信息, 2010, 26(4), 4—18)
|
[7] |
Yao Y., Li Z. S., Chem. Res. Chinese Universities,2008, 24(6), 778—781
|
[8] |
Barnes D. E., Cenzer I. S., Yaffe K., Ritchie C. S., Lee S. J., Alzheimer’s and Dementia,2014, 10(6), 646—655
|
[9] |
Fauq A. H., Simpson K., Maharvi G. M., Golde T., Das P., Bioorganic and Medicinal Chemistry Letters,2007, 17(22), 6392—6395
|
[10] |
De La R. M., Woo K. H., Esmir G., Cheryl J., Yung-hyo B. U. K., Ilia K., Matthew A., Zhang W. J., Chen H. M., Xu W., Bioorganic and Medicinal Chemistry Letters,2006, 16(17), 4444—4449
|
[11] |
Lukasz R., Nils M., Abdelouahid M., Stephan H., ChemBioChem,2011, 12(3), 371—376
|
[12] |
Hoffmann-Emery F., Jakob-Roetne R., Process for Preparation of Enantiomerically Pure Compounds, US 2008293933,2008-11-27
|
[13] |
Hoffmann-Emery F., Jakob-Roetne R., Alexander F., Fritz B., Reinhard R., Tetrahedron Letters,2009, 50(46), 6380—6382
|
[14] |
James E. A., Thomas E. M., Jeffrey A. N., Stacey L. M., Warren J. P., Polycyclic α-Amino-ε-Caprolactams and Related Compounds US 6958330,2005-10-25
|
[15] |
Wu J., Tung J. S., Thorsett E. D., Pleiss M. A., Nissen J. S., Neitz J. R., Latimer L. H., John V., Freedman S., Britton T. C., Audia J. A., Reel J. K., Mabry T. E., Dressman B. A., Cwi C. L., Droste J. J., Henry S. S., McDaniel S. L., Scott W. L., Stucky R. D., Porter W. J., Cycloalkyl, Lactam Lactone and Related Compounds, Pharmaceutical Compositions Comprising Same, and Methods for Inhibiting Beta-Amyloid Peptide Release and/or Its Synthesis by Use of Such Compounds, EP 951466,2003-10-14
|
[16] |
Degussa A., Novel Phosphinine Compounds and Metal Complexes Thereof, US2002103375, 2002-8-1
|
[17] |
Jens-Uwe P., Galley G., Helmut J., Christian C., Pascale D. P., Eric A. K., Laurence O., Bioorganic and Medicinal Chemistry Letters,2007, 17(21), 5918—5923
|
[18] |
Wu J., Tung J. S., Thorsett E. D., Pleiss M. A., Nissen J. S., Neitz J. R., Latimer L. H., John V., Freedman S., Britton T. C., Audia J. A., Reel J. K., Mabry T. E., Dressman B. A., Cwi C. L., Droste J. J., Henry S. S., McDaniel S. L., Scott W. L., Stucky R. D., Porter W. J., Preparation of Cycloalkyl, Lactam, Lactone and Related Compounds for Inhibiting Beta-Amyloid Peptide Release and Its Synthesis US 200245747,2002-5-9
|
[19] |
Fuwa H., Okamura Y., Morohashi Y., Tomita T., Iwatsubo T., Kan T., Fukuyama T., Natsugari H., Tetrahedron Letters,2004, 45(11), 2323—2326
|
[20] |
Cole K. P., David M., Austin C. M., Stout J. R., Belvo M. D., Tetrahedron: Asymmetry,2009, 20(11), 1262—1266
|
[21] |
Gu J. Y., He W. P., Shi X. F., Ji L. N., Chem. Res. Chinese Universities,2008, 24(1), 106—109
|
[22] |
Chen R.Y., Organic Synthesis Process Optimization, Chemical Industry Press, Beijing, 2005, 42—51
|
|
(陈荣业. 有机合成工艺优化, 北京: 化学工业出版社, 2005, 42—51)
|